[HTML][HTML] Chronic rheumatologic disorders and cardiovascular disease risk in women

PK Mehta, RD Levit, MJ Wood, N Aggarwal… - American Heart Journal …, 2023 - Elsevier
Cardiovascular disease (CVD) is a major health threat to women worldwide. In addition to
traditional CVD risk factors, autoimmune conditions are increasingly being recognized as …

The role of toll like receptors in giant cell arteritis

L O'Neill, ES Molloy - Rheumatology, 2016 - academic.oup.com
GCA is a common primary systemic vasculitis that results in granulomatous inflammation of
medium to large arteries. Both innate and adaptive immune mechanisms combine to drive …

Accelerated atheromatosis and arteriosclerosis in primary systemic vasculitides: current evidence and future perspectives

OD Argyropoulou, AD Protogerou… - Current Opinion in …, 2018 - journals.lww.com
Accelerated atheromatosis and arteriosclerosis or arteriosclerosis are established in some
PSV. The potential clinical value of easy-to-measure and clinically useful noninvasive …

[HTML][HTML] Risk of Cardiovascular Events in Giant Cell Arteritis: Systematic Review and Meta-analysis

SS Rathore, P Srikaram, S Gudena, S Manoj… - Hellenic Journal of …, 2024 - Elsevier
Background Giant cell arteritis (GCA) is a chronic inflammatory condition associated with a
significantly increased risk of various cardiovascular and thromboembolic events. Existing …

Interleukin-6 does not upregulate pro-inflammatory cytokine expression in an ex vivo model of giant cell arteritis

L O'Neill, J McCormick, W Gao, DJ Veale… - … advances in practice, 2019 - academic.oup.com
Objective The aim of this study was to examine the pro-inflammatory effects of IL-6 in ex vivo
temporal artery explant cultures. Methods Patients meeting 1990 ACR classification criteria …

[HTML][HTML] A rare case of coronary artery thrombosis in a patient with recently diagnosed giant cell arteritis: is anticardiolipin antibody involved?

KS Shan, Q Zhang, S Bisaria, A Tewary - Cureus, 2020 - ncbi.nlm.nih.gov
Giant cell arteritis (GCA) is an immune-mediated systemic inflammation of large-sized
arteries that predominantly affects elderly women. It may be considered as one of the risk …

Giant cell arteritis: beyond corticosteroids

L Steel, A Khan, B Dasgupta - Drugs & aging, 2015 - Springer
Giant cell arteritis (GCA) is a large-vessel vasculitis predominantly affecting older people,
with a peak incidence between 70 and 79 years of age. If untreated, ischaemic …

Mast cells and primary systemic vasculitides

D Ribatti, R Tamma, S Ruggieri, T Annese… - …, 2018 - Wiley Online Library
Vasculitides are characterized by inflammation and necrosis of blood vessels leading to
vessel occlusion and ischemic damages of tissues. Among the inflammatory cells involved …

Approach to giant cell arteritis and recent evidence on its relation with cardiovascular risk. A review

RR Crespo, LM Falcão - European Geriatric Medicine, 2016 - Elsevier
Conclusions GCA is a large-vessel vasculitis with a systemic inflammatory component. The
gold standard of its treatment remains high dose corticosteroids, though recent …

[HTML][HTML] Giant Cell Arteritis Presenting with Bilateral Subdural Haematomas of Arterial Origin

A Gabr, K El Kholy, J Crotty, M O'Connor… - European Journal of …, 2016 - ncbi.nlm.nih.gov
Giant cell arteritis or temporal arteritis is an inflammatory condition affecting medium to large
sized vessels, particularly the cranial arteries. A 76-year-old man with no significant past …